AT238328T
Monocyclic l-nucleosides, analogs and uses thereof
Abstract
The novel monocyclic Of nucleoside compound of the general formula (I). The of the terminal of these compounds for treating more of diseases comprising following infection, tumour, and autoimmunity disease. A wherein, the solution is displayed of the activity of the novel compound, putting for adjusting the cell pattern factor, comprising a Th1 of the reaction Th2.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
60 members in 26 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 2858596 | United States of America | P | |
| 9718767 | United States of America | W |
Members60
| Document | Office | Kind | |
|---|---|---|---|
| CA2267279A1 | Canada | A1 | |
| WO9816186A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4986797A | Australia | A | |
| WO9816186A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO991785D0 | Norway | D0 | |
| NO991785L | Norway | L | |
| CZ120699A3 | Czechia | A3 | |
| PL333419A1 | Poland | A1 | |
| IL129126D0 | Israel | D0 | |
| BR9712527A | Brazil | A | |
| SI20076A | Slovenia | A | |
| KR20000049224A | Republic of Korea | A | |
| EP1027359A2 | European Patent Office (EPO) | A2 | |
| CN1268140A | China | A | |
| US6130326A | United States of America | A | |
| NZ334915A | New Zealand | A | |
| SK47199A3 | Slovakia | A3 | |
| HK1028977A1 | Hong Kong, China | A1 | |
| HU0001107A2 | Hungary | A2 | |
| HUP0001107A2 | Hungary | A2 | |
| EP1027359A4 | European Patent Office (EPO) | A4 | |
| EP1132393A1 | European Patent Office (EPO) | A1 | |
| AU738170B2 | Australia | B2 | |
| JP2002503212A | Japan | A | |
| HK1038365A1 | Hong Kong, China | A1 | |
| YU18799A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| US2002095033A1 | United States of America | A1 | |
| RU2188828C2 | Russian Federation | C2 | |
| NO313417B1 | Norway | B1 | |
| EP1254911A1 | European Patent Office (EPO) | A1 | |
| US2003018186A1 | United States of America | A1 | |
| HU0001107A3 | Hungary | A3 | |
| HUP0001107A3 | Hungary | A3 | |
| EP1132393B1 | European Patent Office (EPO) | B1 | |
| AT236921T | Austria | T | |
| ATE236921T1 | Austria | T1 | |
| EP1302474A1 | European Patent Office (EPO) | A1 | |
| US6552183B1 | United States of America | B1 | |
| EP1027359B1 | European Patent Office (EPO) | B1 | |
| AT238328TThis record | Austria | T | |
| ATE238328T1 | Austria | T1 | |
| DE69720811D1 | Germany | D1 | |
| DE69721339D1 | Germany | D1 | |
| US6573248B2 | United States of America | B2 | |
| JP2003176296A | Japan | A | |
| DK1132393T3 | Denmark | T3 | |
| DK1027359T3 | Denmark | T3 | |
| RU2001132536A | Russian Federation | A | |
| PT1132393E | Portugal | E | |
| EP1027359B9 | European Patent Office (EPO) | B9 | |
| KR100398923B1 | Republic of Korea | B1 | |
| PT1027359E | Portugal | E | |
| US6642206B2 | United States of America | B2 | |
| ES2195125T3 | Spain | T3 | |
| ES2195970T3 | Spain | T3 | |
| DE69721339T2 | Germany | T2 | |
| UA63915C2 | Ukraine | C2 | |
| DE69720811T2 | Germany | T2 | |
| PL187107B1 | Poland | B1 | |
| SK284054B6 | Slovakia | B6 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 97912762
Titles2
- German
- MONOZYKLISCHE L-NUKLEOSIDE, ANALOGA UND IHRE ANWENDUNGEN
- English
- MONOCYCLIC L-NUCLEOSIDES, ANALOGUES AND ITS APPLICATIONS
Classification
- CPC, 7
- C07H19/04
- C07H15/20
- A61P31/00
- A61P33/00
- A61P35/00
- A61P37/02
- A61P37/06
- IPC, 26
- C07H15 20
- A61K31 4155
- A61K31 4196
- A61K31 427
- A61K31 70
- A61K31 7056
- A61K31 706
- A61K31 7068
- A61K31 7072
- A61P31 00
- A61P33 00
- A61P35 00
- A61P37 02
- A61P37 06
- C07D405 04
- C07D405 12
- C07D517 00
- C07H7 06
- C07H19 00
- C07H19 04
- C07H19 044
- C07H19 048
- C07H19 052
- C07H19 056
- C07H19 067
- C07H19 12